278 related articles for article (PubMed ID: 36773331)
1. Molecular and cellular basis of the dose-rate-dependent adverse effects of radiation exposure in animal models. Part II: Hematopoietic system, lung and liver.
Suzuki K; Imaoka T; Tomita M; Sasatani M; Doi K; Tanaka S; Kai M; Yamada Y; Kakinuma S
J Radiat Res; 2023 Mar; 64(2):228-249. PubMed ID: 36773331
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular basis of the dose-rate-dependent adverse effects of radiation exposure in animal models. Part I: Mammary gland and digestive tract.
Suzuki K; Imaoka T; Tomita M; Sasatani M; Doi K; Tanaka S; Kai M; Yamada Y; Kakinuma S
J Radiat Res; 2023 Mar; 64(2):210-227. PubMed ID: 36773323
[TBL] [Abstract][Full Text] [Related]
3. Towards a new dose and dose-rate effectiveness factor (DDREF)? Some comments.
Chadwick KH
J Radiol Prot; 2017 Jun; 37(2):422-433. PubMed ID: 28488593
[TBL] [Abstract][Full Text] [Related]
4. THE DOSE AND DOSE-RATE EFFECTIVENESS FACTOR (DDREF).
Wakeford R; Azizova T; Dörr W; Garnier-Laplace J; Hauptmann M; Ozasa K; Rajaraman P; Sakai K; Salomaa S; Sokolnikov M; Stram D; Sun Q; Wojcik A; Woloschak G; Bouffler S; Grosche B; Kai M; Little MP; Shore RE; Walsh L; Rühm W
Health Phys; 2019 Jan; 116(1):96-99. PubMed ID: 30489371
[No Abstract] [Full Text] [Related]
5. The integration of the adverse outcome pathway framework to radiation risk assessment.
Chauhan V; Stricklin D; Cool D
Int J Radiat Biol; 2021; 97(1):60-67. PubMed ID: 32397918
[TBL] [Abstract][Full Text] [Related]
6. The role of dose-rate on risk from internally-deposited radionuclides and the potential need to separate dose-rate effectiveness factor (DREF) from the dose and dose-rate effectiveness factor (DDREF).
Brooks AL; Eberlein PE; Couch LA; Boecker BB
Health Phys; 2009 Nov; 97(5):458-69. PubMed ID: 19820455
[TBL] [Abstract][Full Text] [Related]
7. The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation.
Brooks AL; Hoel DG; Preston RJ
Int J Radiat Biol; 2016 Aug; 92(8):405-26. PubMed ID: 27266588
[TBL] [Abstract][Full Text] [Related]
8. On the estimation of radiation-induced cancer risks from very low doses of radiation and how to communicate these risks.
Mattsson S; Nilsson M
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):17-21. PubMed ID: 25802468
[TBL] [Abstract][Full Text] [Related]
9. A case example of a radiation-relevant adverse outcome pathway to lung cancer.
Chauhan V; Sherman S; Said Z; Yauk CL; Stainforth R
Int J Radiat Biol; 2021; 97(1):68-84. PubMed ID: 31846388
[TBL] [Abstract][Full Text] [Related]
10. Dose and dose-rate effects of ionizing radiation: a discussion in the light of radiological protection.
Rühm W; Woloschak GE; Shore RE; Azizova TV; Grosche B; Niwa O; Akiba S; Ono T; Suzuki K; Iwasaki T; Ban N; Kai M; Clement CH; Bouffler S; Toma H; Hamada N
Radiat Environ Biophys; 2015 Nov; 54(4):379-401. PubMed ID: 26343037
[TBL] [Abstract][Full Text] [Related]
11. Integrating basic radiobiological science and epidemiological studies: why and how.
Preston RJ
Health Phys; 2015 Feb; 108(2):125-30. PubMed ID: 25551492
[TBL] [Abstract][Full Text] [Related]
12. Uncertainties in estimating health risks associated with exposure to ionising radiation.
Preston RJ; Boice JD; Brill AB; Chakraborty R; Conolly R; Hoffman FO; Hornung RW; Kocher DC; Land CE; Shore RE; Woloschak GE
J Radiol Prot; 2013 Sep; 33(3):573-88. PubMed ID: 23803503
[TBL] [Abstract][Full Text] [Related]
13. Nuclear epidemiologic studies and the estimation of DREF.
Hoel DG
Int J Radiat Biol; 2018 Apr; 94(4):307-314. PubMed ID: 29400635
[TBL] [Abstract][Full Text] [Related]
14. The impact of dose rate on the linear no threshold hypothesis.
Brooks AL
Chem Biol Interact; 2019 Mar; 301():68-80. PubMed ID: 30763551
[TBL] [Abstract][Full Text] [Related]
15. Dose and dose rate effectiveness of space radiation.
Schimmerling W; Cucinotta FA
Radiat Prot Dosimetry; 2006; 122(1-4):349-53. PubMed ID: 17169950
[TBL] [Abstract][Full Text] [Related]
16. An Assessment of Radiation Doses From Radon Exposures Using a Mouse Model System.
Mirsch J; Hintz L; Maier A; Fournier C; Löbrich M
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):770-778. PubMed ID: 32473181
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
Harrison JD; Muirhead CR
Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
[TBL] [Abstract][Full Text] [Related]
18. Concerning the health effects of internally deposited radionuclides.
Raabe OG
Health Phys; 2010 Mar; 98(3):515-36. PubMed ID: 20147792
[TBL] [Abstract][Full Text] [Related]
19. The effect of dose rate on radiation-induced neoplastic transformation in vitro by low doses of low-LET radiation.
Elmore E; Lao XY; Kapadia R; Redpath JL
Radiat Res; 2006 Dec; 166(6):832-8. PubMed ID: 17149982
[TBL] [Abstract][Full Text] [Related]
20. Current discussions of DDREF, cataracts, circulatory diseases and dose limits.
Müller WU
Radiat Prot Dosimetry; 2015 Apr; 164(1-2):34-7. PubMed ID: 25313174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
